Iambic Therapeutics
Agent31Agent Readiness: 31/100. Below median. Measured by StartupHub.ai. Median 41.Trust90Data Trust: 90/100. Top 25%. Measured by StartupHub.ai. Median 61.AI-driven drug discovery company developing novel medicines for unmet patient needs.
We may earn a commission from links on this Iambic Therapeutics profile. That does not change the facts we publish.
About
Iambic Therapeutics is a clinical-stage life science and technology company that develops novel medicines using its AI-driven discovery and development platform. Founded in 2019, the company integrates artificial intelligence with physics principles to tackle complex molecular design challenges, aiming to accelerate drug discovery timelines and reduce development risks for pharmaceutical and biotech organizations.
Listed competitors
Data-driven drug discovery and development company using machine learning and high-throughput biology.
AI-driven biotechnology company developing novel protein therapeutics through generative biology.
Clinical-stage precision medicine company using protein motion insights for drug discovery.
Also in this space
AI-powered website builder that creates professional websites in minutes from a simple description.
Shares Generative AI
AI-powered platform for understanding disease biology and accelerating drug discovery.
Shares Biotech, Drug Discovery
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Biotech, Drug Discovery
AI-powered biotechnology company developing RNA therapeutics for genetic diseases.
Shares Biotech, Drug Discovery
NewLimit is developing epigenetic therapies to extend human healthspan by reprogramming aging cells.
Shares Biotech, Drug Discovery
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, HealthTech
Key facts
- Website
- iambic.ai
- Headquarters
- San Diego, United States
- Founded
- 2019
- Employees
- 151
- Total funding
- $50M (Series B Extension)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 18 Jun 2024 | Series B Extension | $50M | Mubadala Capital, Exor Ventures |
Tech stack
Detected on iambic.ai, last scanned 24 Oct 2026. Run your own scan
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Affiliate program
- Self-hosted affiliate
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Iambic Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Iambic Therapeutics is 90 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Iambic Therapeutics raised?
Iambic Therapeutics has raised a total of $50M in funding. The most recent round on record is Series B Extension.
How many employees does Iambic Therapeutics have?
Iambic Therapeutics has approximately 151 people on record.
Does Iambic Therapeutics have an affiliate program?
Yes, Iambic Therapeutics has an affiliate program. The program runs on Self-hosted affiliate. Register here: iambic.ai/affiliates
SEC filings, insider activity, nonprofit links and pay benchmarks for Iambic Therapeutics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
